Gemfibrozil has the following features except:
A. It lowers plasma LDL cholesterol to a greater
extent than triglycerides
B. It tends to raise plasma HDL-cholesterol level
C. It is a first line drug for type III, type IV and
type V hyperlipoproteinemia
D. It reduces the incidence of myocardial infarctio
A. It lowers plasma LDL cholesterol to a greater
extent than triglycerides
B. It tends to raise plasma HDL-cholesterol level
C. It is a first line drug for type III, type IV and
type V hyperlipoproteinemia
D. It reduces the incidence of myocardial infarctio